Literature DB >> 9604230

[Combination therapy of endemic goiter with two different thyroxine/iodine combinations].

B Klemenz1, G Förster, H Wieler, G Kahaly, K P Kaiser, C Hansen, P Willkomm, J Ruhlmann.   

Abstract

AIM: Of this study was to investigate the extent of thyrotropin (TSH) suppression and volume reduction in combination therapy of endemic goitre. We compared an individually adapted dose of thyroxine with a fixed dose.
METHODS: 105 patients of a multicenter study (randomised, single blinded, controlled) received daily a weight-adjusted LT4-dose in combination with 150 micrograms iodide (group A) or a fixed combination of 100 micrograms LT4 plus 100 micrograms iodide (group B), respectively. At the beginning and after 12 weeks TSH-levels and goitre volume were examined.
RESULTS: Although the amount of thyrotropin suppression showed no differences in both groups, there were more patients in the weight-adjusted treatment group with completely suppressed thyrotropin serum concentrations (p < 0.05). Both groups showed a reduction of goitre volume of 24%
CONCLUSION: A weight-adjusted LT4-dose of 1.4 micrograms/kg body weight often leads to subclinical hyperthyroidism. To obtain low TSH-levels without complete suppression LT4-doses of 1.0 microgram/kg body weight plus 150 micrograms iodide are probably sufficient.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9604230

Source DB:  PubMed          Journal:  Nuklearmedizin        ISSN: 0029-5566            Impact factor:   1.379


  1 in total

1.  [Optimal recurrence prevention of iodine deficiency related goiter after thyroid gland operation. A prospective clinical study].

Authors:  P M Schumm-Draeger; A Encke; K H Usadel
Journal:  Internist (Berl)       Date:  2003-04       Impact factor: 0.743

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.